A new report from the Office of Inspector General revealed that the three largest Medicare Advantage insurers denied prior authorization requests for long-term acute care and inpatient rehabilitation at high
Bot vs. Bot: Why Healthcare AI Progress Might Be Stuck
Healthcare is in the middle of an AI gold rush, with investors, providers and payers pouring more money than ever before into new technology. But according to a group of
Stop Presenting at Health-Tech Buyers — Let Them Drive
Apparently, it’s not just me. I’m probably like most buyers of products or services, especially those in high tech. Watching a video of some other person using or demonstrating a
Abridge Goes Beyond Documentation: 4 Updates
Clinical AI startup Abridge is one of the most well-funded health tech startups in the nation, having raised $1.1 billion since its founding in 2018. On Thursday, the startup held
Novartis RNA Med From $12B Deal Keeps Building Case to Become First Therapy for Rare Muscle Disease
A Novartis RNA therapy reduced blood levels of a protein that’s a biological indicator of a particular form of muscular dystrophy, clinical trial results that could support an application seeking
The Identity Gap Undermining Value-Based Care
Value-based care (VBC) goals include better outcomes and sustainable reimbursement. But it won’t work if organizations can’t accurately attribute patients, providers, and encounters across an increasingly complex ecosystem. Many healthcare
DiMe Launches New Initiative for Virtual-First Care
The Digital Medicine Society (DiMe) unveiled a new initiative on Tuesday during the AHIP 2026 Conference that aims to create best practices for contracting with virtual care providers. DiMe is
‘2030 Scares Me to Death’: Credit Analysts’ Urgent Warning for Healthcare CFOs
If you want to know where healthcare finance is headed, ask the people who lend hospitals money. During a Tuesday panel at the HFMA Annual Conference in National Harbor, Maryland,
Take Part in Our Survey on Healthcare AI and Security
Health insurers are keen to assess the value and effectiveness of AI applications across different parts of their businesses. But in which areas is their attention focused? What does success
The 5 Areas Where Dr. Oz Says CMS Can Make Healthcare More Affordable
CMS Administrator Dr. Mehmet Oz is optimistic about Washington’s ability to bend the healthcare cost curve, he said during a Tuesday address at the HFMA Annual Conference in National Harbor,









